相关实验视频

Updated: Mar 10, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

在帕金森病中皮肤下白质过强度和运动功能:ONDRI研究的发现

Daniela Cristina Carvalho de Abreu^1,2,3, Frederico Pieruccini-Faria^4,5, Anthony E Lang⁶

¹Department of Medicine, Division of Geriatric Medicine, Parkwood Hospital, Western University, London, Ontario, Canada. dabreu@fmrp.usp.br.

|June 7, 2025

概括

基底和丘脑 (BGT) 中的白质过强度 (WMH) 与帕金森病 (PD) 患者的更好的运动功能有关. 在这项研究中,皮层WMH与运动征兆没有关联.

科学领域:

神经学神经学
神经成像是一种神经成像.
运动障碍运动障碍

背景情况:

异常性帕金森病 (PD) 具有诸如刚性和勃拉迪基尼西亚等运动症状的特征.
基底质中多巴胺活性降低有助于PD运动症状.
白质过强度 (WMH) 在基底质对运动征兆的影响尚不清楚.

研究的目的:

检查皮下白质高强度 (WMH) 的负担与帕金森病 (PD) 运动障碍之间的关系.

主要方法:

这是一项对140名来自安大略省神经退行性疾病研究计划 (ONDRI) 的PD参与者的横截面研究.
在整个大脑,叶片和基底质+thalamus (BGT) 中计算出相对WMH百分比.
使用调整后回归模型和ANCOVA分析WMH与运动标志的关联,分层分为四分位数的WMH负担.

主要成果:

基底质+丘脑 (BGT) 中WMH负荷增加与PD参与者的更好的运动功能相关.
在皮层区域 (额头,,,) 的WMH与运动信号严重性无关.
与较低体积的PD参与者相比,具有较高BGT WMH体积的PD参与者表现出优越的运动功能.

结论:

基底质+脑丘脑 (BGT) 的高强度病变与帕金森病中运动功能的改善显著相关.
这表明,基底质回路中断可能会调节运动输出,为PD机制提供新的见解.
结果是相关的,需要进一步的机制和治疗研究.

关键词:

这就是MDS-UPDRS-III.汽车标志汽车标志汽车标志神经退行性疾病的神经退行性疾病白质的超强度是白质的超强度.

更多相关视频

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.